As a reminder, this is Finom Group’s off-reporting weekend, however we continue to disseminate relevant and trusted 3rd-party research by the former chief equity strategist of The Leuthold Group, Jim Paulsen. We’ll see you back here next weekend with our proprietary research report and revised S&P 500 price target for the forward 12-month period. Currently, many well-respective strategists are concerned…
The Unemployment Rate and Stock Market
A financial market resource for the every-day investor and trader.
-
Weekly State of the Market: Market Malaise Manifests
Seth Golden, , Research Reports, 0
“An investor’s job is not to avoid the pain but to endure it.” If you would like to...
-
Merrill Lynch Capital Market Outlook: December 2019
Seth Golden, , Research Reports, 0
IN THIS ISSUE Macro Strategy—A fundamental change in the Federal Reserve’s (Fed’s) approach to achieving its inflation target means...
-
Weekly State of the Market: Seasonal Misstep, But Data Guides The Way
Seth Golden, , Research Reports, 0
Spend 2 seconds on FinTwit and you’ll see why equities fell 5% in Sept, rose 10% in Oct and...
-
Weekly State of the Market: September Getting Dicey Already?
Seth Golden, , Research Reports, 0
Keep it simple and know your ABC’s of investing: Always, Buy, Corrections!! If you would like to watch...
-
Haven’t Broken The Bear’s Back… Yet
Seth Golden, , Research Reports, 0
I’ll be flying solo for this weekend’s Research Report, as Edward is off this weekend. So forgive any shortcomings...
-
Weekly State of the Market: Little White Lies
Seth Golden, , Research Reports, 0
All intelligent investing is value investing, acquiring more than you are paying for. You must value the business in...
-
Morgan Stanley Biotechnology Team: Year-End Vaccine Probable
Seth Golden, , Research Reports, 0
Biotechnology | North America COVID-19: Increasing ConvictionMultiple Vaccine Candidates WillHave Pivotal Data Before YE20 While a pre-election result is...
-
The 4th Quarter: And So It Begins
Seth Golden, , Research Reports, 0
Although we haven’t quite hit the earnings season stride, usually marked by the financials reporting results, investors will roll...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00